Clinical Trial

Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home

Study acronym: NUTREAT
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with cancer have increased risk of malnutrition due to the disease itself and the treatment regimen they undergo. This is particularly relevant for patients with head and neck cancer (HNC), where 74%-95% are malnourished. HNC is a heterogenous group of cancers, including oral cavity, larynx, pharynx and salivary glands. The present project will study the effectiveness and implementation of remote patient monitoring of nutrition and tailored nutrition support throughout the treatment course in patients with head and neck cancer. The implementation will be evaluated in a randomized controlled trial (RCT), and the aim of the project is to reduce the prevalence of malnutrition and increase the quality of life among patients with HNC.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-08-09; most recent amendment 2025-09-01.
Status change: Recruiting → Active, Not Recruiting 2025-08-25
Status change: Not Yet Recruiting → Recruiting 2025-04-02
Trial Details
NCT Number NCT05997329
Lead Sponsor University of Oslo
Collaborators: Oslo University Hospital, University of South-Eastern Norway
Conditions Head and Neck Cancer
Enrollment 125 participants
Start Date 2023-11-01
Primary Completion 2025-10-30 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-08